Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
An urgent NHS safety alert warns that thousands of patients on a common medication for arthritis and skin conditions face heightened risks of blindness and serious lung disease. Experts call for immediate patient reviews.
Explosive revelations suggest Donald Trump pressured the FDA to approve unproven Covid-19 drugs, risking public health for political gain. New evidence raises ethical concerns.